Caliway Biopharmaceuticals (6919.TW) Q2 2025 Earnings

May 5Confirmed
Q4 2024
Q1 2025
Q2 2025
-1.36
-0.94
-0.52
-0.1

Details

Expected EPS
-0.12883564512
Actual EPS
-0.09991335744
Surprise EPS
0.03
Surprise Percent
+22.45%

Description

⁨Caliway Biopharmaceuticals⁩ (⁦6919.TW⁩) has reported earnings of ⁦-0.09991335744⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts